Cargando…

Extracellular Vesicle-Derived Protein File from Peripheral Blood Predicts Immune-Related Adverse Events in Gastric Cancer Patients Receiving Immunotherapy

SIMPLE SUMMARY: Most gastric cancer (GC) patients have already benefited from immune checkpoint inhibitors, but some of them may terminate immunotherapy due to immune-related adverse events (irAEs). Extracellular vesicles have been shown to carry proteins, nucleic acids and other biomacromolecules t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Fangli, Zhang, Zhening, Chong, Xiaoyi, Shen, Lin, Fan, Meng, Liu, Xuan, An, Jin, Peng, Zhi, Zhang, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454680/ https://www.ncbi.nlm.nih.gov/pubmed/36077704 http://dx.doi.org/10.3390/cancers14174167

Ejemplares similares

Plasma extracellular vesicle derived protein profile predicting and monitoring immunotherapeutic outcomes of gastric cancer
por: Zhang, Cheng, et al.
Publicado: (2022)

Peripheral Blood Biomarkers Predictive of Efficacy Outcome and Immune-Related Adverse Events in Advanced Gastrointestinal Cancers Treated with Checkpoint Inhibitors
por: Zhang, Zhening, et al.
Publicado: (2022)

Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy
por: Jing, Ying, et al.
Publicado: (2022)

Extracellular Vesicles as Biomarkers in Cancer Immunotherapy
por: Mathew, Matthen, et al.
Publicado: (2020)

Gastrointestinal adverse events of immunotherapy
por: Cappello, Giovanni, et al.
Publicado: (2021)

Appropriate PD-L1 Cutoff Value for Gastric Cancer Immunotherapy: A Systematic Review and Meta-Analysis
por: Xie, Tong, et al.
Publicado: (2021)

Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy
por: Xie, Feng, et al.
Publicado: (2019)

Extracellular Vesicles and Their Current Role in Cancer Immunotherapy
por: Giacobino, Carla, et al.
Publicado: (2021)

Bacterial extracellular vesicle applications in cancer immunotherapy()
por: Suri, Kanika, et al.
Publicado: (2022)

Surface-Engineered Extracellular Vesicles in Cancer Immunotherapy
por: Johnson, Vinith, et al.
Publicado: (2023)

The role and application of small extracellular vesicles in gastric cancer
por: Wu, Hao, et al.
Publicado: (2021)

Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapy
por: Park, Kyong‐Su, et al.
Publicado: (2021)

The Control of Event-File Management
por: Hommel, Bernhard
Publicado: (2022)

Extracellular vesicles in osteoarthritis of peripheral joint and temporomandibular joint
por: Yang, Benyi, et al.
Publicado: (2023)

Adverse Events of Oncologic Immunotherapy and Their Management
por: Barber, Fedricker Diane
Publicado: (2019)

Neurologic adverse events of cancer immunotherapy
por: de Brito, Marcelo Houat
Publicado: (2022)

An inconvenient truth: file-level metadata and in-file metadata caching in the (file-agnostic) ATLAS event store
por: Malon, D, et al.
Publicado: (2008)

Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy
por: Srivastava, Akhil, et al.
Publicado: (2021)

Extracellular vesicle–based drug delivery in cancer immunotherapy
por: Najafi, Sajad, et al.
Publicado: (2023)

Using risk management files to identify and address causative factors associated with adverse events in pediatrics
por: Hain, Paul D, et al.
Publicado: (2007)

Positive Status of Epstein-Barr Virus as a Biomarker for Gastric Cancer Immunotherapy: A Prospective Observational Study
por: Xie, Tong, et al.
Publicado: (2020)

Small RNA fingerprinting of Alzheimer’s disease frontal cortex extracellular vesicles and their comparison with peripheral extracellular vesicles
por: Cheng, Lesley, et al.
Publicado: (2020)

Predictability reduces event file retrieval
por: Schmalbrock, Philip, et al.
Publicado: (2022)

Rheumatological Adverse Events Following Immunotherapy for Cancer
por: Cretu, Ioana, et al.
Publicado: (2022)

Characteristics of dust mite sublingual immunotherapy-associated adverse events in the early phase
por: Chen, Ming, et al.
Publicado: (2022)

Extracellular vesicles in venous thromboembolism and pulmonary hypertension
por: Zhang, Jiwei, et al.
Publicado: (2023)

Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy
por: Taghikhani, Adeleh, et al.
Publicado: (2020)

Tumor-Derived Extracellular Vesicles: Their Role in Immune Cells and Immunotherapy
por: Li, Qi, et al.
Publicado: (2021)

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
por: Unger, Joseph M., et al.
Publicado: (2022)

The Predictive Model Construction for Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immunotherapy
por: Gao, Weitong, et al.
Publicado: (2023)

Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy
por: Tong, Qing, et al.
Publicado: (2023)

Adaptive design of mRNA-loaded extracellular vesicles for targeted immunotherapy of cancer
por: Dong, Shiyan, et al.
Publicado: (2023)

Analysis of Extracellular Vesicles in Gastric Juice from Gastric Cancer Patients
por: Kagota, Shuji, et al.
Publicado: (2019)

Isolation and Characterization of Extracellular Vesicles from Gastric Juice
por: Skryabin, Gleb O., et al.
Publicado: (2022)

Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy
por: Yeung, Howa, et al.
Publicado: (2023)

Understanding adverse events of immunotherapy: A mechanistic perspective
por: Burke, Kelly P., et al.
Publicado: (2020)

Immune-related adverse events and the balancing act of immunotherapy
por: Conroy, Michael, et al.
Publicado: (2022)

Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer
por: Rahman, Md. Mominur, et al.
Publicado: (2022)

Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy
por: Liu, Xiaoming, et al.
Publicado: (2022)

Immune Regulation by Dendritic Cell Extracellular Vesicles in Cancer Immunotherapy and Vaccines
por: Fernández-Delgado, Irene, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h7a67n1rcc7mkhqdssmgi9jbde